NDUFB9 anticorps (C-Term)

N° du produit ABIN500208

Détail du produit anti-NDUFB9 anticorps

Antigène: NDUFB9 (NADH Dehydrogenase (Ubiquinone) 1 beta Subcomplex, 9, 22kDa (NDUFB9))

Épitope: C-Term

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp NDUFB9 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)

Réactivité croisée (Details): Species reactivity (tested):Human, mouse, rat

Purification: Peptide affinity chromatography

Immunogène: LYRM3 antibody was raised against a 17 amino acid peptide near the carboxy terminus of human LYRM3.

Isotype: IgG

Information d'application

Indications d'application: ELISA. Western blot: 1 - 2 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Concentration: 1.0 mg/mL

Buffer: PBS containing 0.02 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: -20 °C

Stockage commentaire: Store the antibody (in aliquots) at -20 °C.

Détails sur NDUFB9

Antigène: NDUFB9 (NADH Dehydrogenase (Ubiquinone) 1 beta Subcomplex, 9, 22kDa (NDUFB9))

Autre désignation: NDUFB9 (NDUFB9 Produits)

Synonymes: anticorps 1190008J14Rik, anticorps B22, anticorps CI-B22, anticorps LYRM3, anticorps UQOR22, anticorps NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, anticorps NADH:ubiquinone oxidoreductase subunit B9, anticorps Ndufb9, anticorps NDUFB9

Sujet: LYRM3, also known as NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 (NDUFB9), is a ubiquitously expressed LYR-motif containing protein. It has been suggested to be a candidate gene for the branchio-oto-renal (BOR) syndrome, which is characterized by branchial and renal abnormalities and heredity deafness disorders. Other than its LYR-motif, LYRM3 appears to have no functional or structural relationship to either LYRM1 or LYRM2.Synonyms: Complex I-B22, LYR motif-containing protein 3, LYRM3, NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9, NADH-ubiquinone oxidoreductase B22, UQOR22

ID gène: 4715

UniProt: Q9Y6M9

Pathways: Sensory Perception of Sound, SARS-CoV-2 Protein Interactome